Microbiologist explains COVID jab effects: Dr. Sucharit Bhakdi
++++
Reference 5 backup: FLCCC Alliance: MATH+ Hospital Treatment Protocol for COVID-19
Reference 6 contains an error. Should be volume 2, pages 4-22 instead of volume 1, same pages. Abstract from the publication:
Objective: This report is a case series of consecutive patients diagnosed with COVID-19 treated with a nutritional and oxidative medical approach. We describe the treatment program and report the response of the 107 COVID-19 patients.
StudyDesign: Observationalcaseseriesconsecutive.
Setting: A family practice office in a suburb of Detroit, Michigan.
Patients: All patients seen in the office from February through May 2020 diagnosed with COVID-19 were included in the study. COVID-19 was either diagnosed via PCR or antibody testing as well as those not tested diagnosed via symptomology.
Interventions: Oral Vitamins A, C, D, and iodine were given to 107 subjects (99%). Intravenous solutions of hydrogen peroxide and Vitamin C were given to 32 (30%) and 37 (35%) subjects. Thirty-seven (35%) of the cohort was treated with intramuscular ozone. A dilute, nebulized hydrogen peroxide/saline mixture, with Lugol’s iodine, was used by 91 (85%).
Main Outcome Measures: History and physical exam were reviewed for COVID-19 symptoms including cough, fever, shortness of breath, and gastrointestinal complaints. Laboratory reports were examined for SARS-CoV-2 results. Symptomatic improvement after treatment was reported for each patient consisting of first improvement, mostly better, and completely better.
Results: There were a total of 107 pa- tients diagnosed with COVID-19. Thirty- four were tested for SARS-CoV-2(32%) and twenty-seven (25%) tested positive. Three were hospitalized (3%) with two of the three hospitalized before instituting treatment and only one requiring hospitalization after begin- ning treatment. There were no deaths. The most common symptoms in the cohort were fever (81%), shortness of breath (68%), URI which included cough (69%), and gastroin- testinal distress symptoms (27%). For the entire cohort, first improvement was noted in 2.4 days. The cohort reported symptoms mostly better after 4.4 days and completely better 6.9 days after starting the program. For the SARS-CoV-2 test positive patients, fever was present in 25 (93%), shortness of breath in 20 (74%) and upper respiratory symptoms including cough in 21 (78%) while gastroin- testinal symptoms were present in 9 (33%). The time to improvement in the SARS-CoV- 2 test positive group was slightly longer than the entire cohort.
Conclusion: At present, there is no pub- lished cure, treatment, or preventive for COVID-19 except for a recent report on dex- amethasone for seriously ill patients. A novel treatment program combining nutritional and oxidative therapies was shown to success- fully treat the signs and symptoms of 100% of 107 patients diagnosed with COVID-19. Each patient was treated with an individual- ized plan consisting of a combination of oral, IV, IM, and nebulized nutritional and oxida- tive therapies which resulted in zero deaths and recovery from COVID-19.
Keywords: SARS-CoV-2, COVID-19, ozone therapy, hydrogen peroxie therapy, Vitamin A, iodine, Vitamin C, Vitamin D, immune system, an- tiviral.